Why it exists
Genetic and health data is permanent. Once it’s out, it can’t be unsequenced. But most consumer systems treat that data like any other product analytics stream — fragmented across portals, owned by companies, and inaccessible to the person it came from. Enigma Genetics is designed for the opposite default: the individual is the owner, not the product.
What it is
Enigma Genetics is a platform with three parts:
- GeneVault — a user-controlled vault for genetic and health data, designed so decryption keys are held on user-controlled hardware.
- 0mnimind — an AI health companion that organizes and explains genetic and health data. Pronounced “OmniMind.”
- Consent-governed access — every access request is gated by explicit, scoped, revocable user consent, with a tamper-evident audit trail.
What it isn’t
Enigma Genetics is not a medical device, not a diagnostic service, and not a substitute for medical care. 0mnimind does not diagnose, treat, or prescribe. Enigma Genetics is also not affiliated with the ENIGMA Consortium, Enigma Genomics, OmniMind.ai, or other similarly named organizations.
Where it is today
Enigma Genetics is in early access. Many platform features — including specific cryptographic primitives, partner integrations, and certifications — are part of an active roadmap. See compliance roadmap and security for current status.
How to learn more
Read the whitepaper, explore the how-it-works page, browse the glossary, or read the FAQ.